| Literature DB >> 27274816 |
Alison Thomas1, Samuel A Silver1, Andrea Rathe1, Pamela Robinson1, Ron Wald2, Chaim M Bell3, Ziv Harel2.
Abstract
BACKGROUND: Patients with end-stage renal disease are at high risk for medical errors given their comorbidities, polypharmacy and coordination of care with other hospital departments. We previously developed a hemodialysis safety checklist (Hemo Pause) to be jointly completed by nurses and patients. Our objective was to determine the feasibility of using this checklist during every hemodialysis session for 3 months.Entities:
Keywords: checklist; hemodialysis; patient safety; quality improvement
Year: 2016 PMID: 27274816 PMCID: PMC4886914 DOI: 10.1093/ckj/sfw019
Source DB: PubMed Journal: Clin Kidney J ISSN: 2048-8505
Fig. 1.Hemodialysis safety checklist (Hemo Pause). CVC, central venous catheter.
Baseline characteristics of the Hemo Pause patients
| Characteristic | Hemo Pause cohort ( |
|---|---|
| Mean age, years (SD) | 59 (11) |
| Male, | 15 (68) |
| Mean duration on dialysis, years (SD) | 6.9 (5.9) |
| Mean number of medications (SD) | 13.6 (4.1) |
| Number of dialysis days per week, | |
| median (IQR) | 3.0 (2.3) |
| Dialysis access, | |
| Fistula | 13 (59) |
| Graft | 3 (14) |
| Central venous catheter | 6 (27) |
| Comorbidities, | |
| Diabetes | 9 (41) |
| Hypertension | 20 (91) |
| Coronary artery disease | 9 (41) |
| Congestive heart failure | 1 (5) |
| Chronic obstructive pulmonary disease | 2 (9) |
| Peripheral vascular disease | 2 (9) |
| Cerebrovascular disease | 1 (5) |
| Cancer | 0 (0) |
Fig. 2.The percentage of the Hemo Pause checklists in the patient chart completed on a weekly basis. Upper and lower control limits (UCL and LCL) are plotted at ±3 SDs from the mean. A shortage of nurses trained in administration of the Hemo Pause checklist started the second week of July.
Fig. 3.Patient safety survey results. The top panel represents nurse responses and the bottom panel patient responses. A 5-point Likert scale from strongly agree (5) to strongly disagree (1) was used to score the surveys.
Quality of care and adverse events before and after the Hemo Pause implementation
| Pre-checklist | Post-checklist | P-value | |||
|---|---|---|---|---|---|
| % | % | ||||
| Hemodialysis treatments | 799 | 757 | |||
| Pre-weights missed | 1 | 0 | 12 | 2 | 0.01 |
| Post-weights missed | 18 | 2 | 27 | 4 | 0.13 |
| Pre-blood pressures missed | 452 | 57 | 385 | 51 | 0.03 |
| Post-blood pressures missed | 320 | 40 | 276 | 36 | 0.16 |
| Incorrect hemodialysis prescription | 16 | 2 | 13 | 2 | 0.71 |
| Missed hemodialysis session | 24 | 3 | 24 | 3 | 0.88 |
| Missed medication administration | 8 | 1 | 14 | 2 | 0.19 |
| Missed physician orders | 8 | 1 | 5 | 1 | 0.58 |
| More than two cannulation attempts | 0 | 0 | 0 | 0 | N/A |
| Needle dislodgements | 0 | 0 | 0 | 0 | N/A |
| Access infections | 0 | 0 | 0 | 0 | N/A |
| Access interventions | 2 | 0 | 2 | 0 | 1.00 |
| Blood transfusions | 8 | 1 | 2 | 0 | 0.11 |
| Falls | 0 | 0 | 0 | 0 | N/A |
| Systolic blood pressure <90 mmHg during hemodialysis | 5 | 1 | 22 | 3 | 0.01 |
| Hospitalizations | 3 | 0 | 1 | 0 | 0.62 |
| Deaths | 0 | 0 | 0 | 0 | N/A |